Hey, guess what? In April we're making our data free for community health providers, local employers, researchers, and select innovators. This new Community Tier of Turquoise Rates and Contracts will be available at no cost. No hidden fees; just free data. Seriously, free. Zippo. Nada. Free 99. For nothin'. Gratis. No es nada. No-cost. Zero dollars. Zilch. No charge. On the house. F-r-e-e. Free. Join the waitlist, here: https://lnkd.in/g6wi62wd #pricetransparency #startups #healthcare #healthtech
Turquoise Health
软件开发
San Diego，CA 17,066 位关注者
Eliminating the financial complexity of healthcare.
关于我们
Turquoise Health is an end-to-end healthcare pricing platform. Using data from hospital and payer machine-readable files, Turquoise is powering a new marketplace for patients, providers, and payers. By connecting stakeholders across the aisle, Turquoise has dedicated itself to eliminating the financial complexity of healthcare. Learn more at turquoise.health.
- 网站
-
https://turquoise.health
Turquoise Health的外部链接
- 所属行业
- 软件开发
- 规模
- 51-200 人
- 总部
- San Diego，CA
- 类型
- 私人持股
- 创立
- 2020
地点
-
主要
获取路线
US，CA，San Diego，92101
Turquoise Health员工
动态
-
Who needs The Hitchhiker's Guide to the Galaxy when you have The Drug Manufacturer's Guide to #transparencyincoverage Prescription Drug File? Not the same? Not even a little? We humbly disagree. Turquoise's own Mischka Moechtar breaks down all the secrets to the could-be-Pharmacy-Benefit-Drug-Rate Universe in this blog, check it out: https://lnkd.in/g7tF4NKx #pricetransparency #drugs #pbms
-
-
Free data. Like *free* free. Seriously. #pricetransparency
Big, fun news: In April, we’re releasing a Community Tier of Turquoise Rates and Contracts available at no cost. Tell your friends! (Especially if your friends are local providers, employers and startups). Over the past 4 years in the transparency business, we’ve seen a need to make price transparency data more accessible to local organizations. Like the government behind the price transparency regs, we believe that healthy competition starts at the local level. Over the coming weeks, we’re releasing the Community Tier to non-hospital community health providers, employers, local non-profits and researchers, and a select cohort of startups. This tier is designed for local orgs: it’s self-service, has limited seats, and is intended for internal use (aside from the innovator cohort, details below). It will include platform-based access to price transparency disclosure data, including payer negotiated rates, list prices, and cash prices within a region. It will have fewer features compared to our paid offerings, but it will pack a punch. For community health providers and employers, we’ll also offer limited self-service access to Clear Contracts, our AI-powered platform for contract management and negotiation. The employer offering is intended for health plan administrators. For a cohort of small (growing) startups and research organizations innovating in patient access and transparency, we’ll offer an engineer-friendly, self-service cut of transparency data intended to help you find product market fit and prove that we can collectively create savvy consumers of healthcare in the United States. Visit the link below to sign up for the waitlist and learn more about the Community Tier ahead of our April release. https://lnkd.in/gfYN7sND
-
-
Join Turquoise's own Joe Wisniewski as he takes you through a lightening round of gut-assumptions managed care leaders often make about contracting and ways to combat each. It'll be fun, we promise.
Using AI in Managed Care Contracting
www.dhirubhai.net
-
Look, they wont stop talking about drug pricing and reimbursement data. If you're at Reuters Events Pharma, lend an ear...it's good stuff. They promise ?? #REpharmaUSA #pricetransparency
The Turquoise Health team is excited to attend Reuters Pharma USA 2025 conference in Philadelphia! Join me, Wayne Luan and Mischka Moechtar onsite for an engaging conversation around detailed insights into drug pricing and reimbursement data. See you there! #REpharmaUSA #pricetransparency #healthcare
-
-
With new transparency requirements in place, many employers are asking:?Now what??Compliance feels overwhelming, the data is complex, and using it to drive meaningful change isn’t always clear. I’m excited to join?Ashok Subramanian, CEO & Founder of Centivo, in a discussion moderated by?Ryan Olmstead?of Catalyst for Payment Reform, where we’ll break down: - What price transparency rules mean for employers - How cost disparities impact your workforce - How to use transparency data to build better, more cost-effective provider networks - Practical strategies to improve healthcare benefits with affordability and clarity - Employers have a real opportunity to take control of healthcare costs while improving quality. Looking forward to the conversation and hope to see you there! Join us live on March 18th?– register here: https://bit.ly/4ircXyj
-
-
Alright folks, no cheating. What does UDS stand for? Our money is on U-Wish-Please Discount Simulator but hey, that's just us. After you vote, find the answer here: https://lnkd.in/gv9Ngda7 #benefits #healthcare #pricetransparency
此处无法显示此内容
在领英 APP 中访问此内容等
-
Price transparency is one of the few bipartisan things left in Washington. Whether you are right or left on healthcare, we all need to know what it costs. As Chris Severn likes to say, it's a beautiful day for price transparency! https://lnkd.in/gAUQM-7A #pricetransparency #healthcarepolicy
-
Wow - talk about a wild afternoon for transparency enthusiasts like me. President Trump signed another Price Transparency Executive Order into law, nearly six years since the 2019 EOs that catalyzed modern price transparency (and Turquoise's founding) - TL&DR, he's doubling down and wants price transparency efforts to dramatically accelerate. We at Turquoise Health were already in a frenzy by the time we realized the EO references two stats from our data publications last year: 1) PT data shows a savings opportunity of 27% for employers across shoppable services, and 2) top of market prices (inflation adjusted) dropped 6.3% since the rollout of PT data in 2021. Maybe, just maybe, Trump reads our blog on Air Force 1, Lizzie Whitsel, Forrest Xiao? We welcome the administration's re-emphasis on price transparency and believe now more than ever in the potential for healthy competitive markets and empowered consumers to drive price reform in healthcare. Some highlights & reading between the lines (see the full EO text below): - Heavy focus on expeditious enforcement of the *existing* PT laws. I'd expect to see Payer MRF enforcement finally take shape as well as wide-sweeping hospital enforcement. - Disclosure of prescription drug prices (likely a focus on the full flow of funds) back on the table and in the admin's crosshairs. - Potential for *expansion* of price transparency requirements (as opposed to rollback or DOGE-slashing of regulation as some feared). In draft laws in congress last year, expansion PT requirements for labs, ASCs, and freestanding imaging. We'll see a policy proposal 90 days from this EO. Fast times for price transparency in America - we at Turquoise will keep you posted.